Perfluorooctanoate and changes in anthropometric parameters with age in young girls in the Greater Cincinnati and San Francisco Bay Area
- PMID: 31300293
- PMCID: PMC6739850
- DOI: 10.1016/j.ijheh.2019.07.002
Perfluorooctanoate and changes in anthropometric parameters with age in young girls in the Greater Cincinnati and San Francisco Bay Area
Abstract
Methods: We conducted a study of per- and polyfluoroalkyl substance biomarkers, including PFOA, in girls from Greater Cincinnati (CIN, N = 353) and the San Francisco Bay Area (SFBA, N = 351). PFOA was measured in the baseline serum sample collected in 2004-2007 of 704 girls at age 6-8 years. Mixed effects models were used to derive the effect of PFOA on BMI, waist-to-height and waist-to-hip ratios over increasing age in this longitudinal cohort.
Results: Median PFOA serum concentrations were 7.3 (CIN) and 5.8 (SFBA) ng/mL, above the U.S. population median for children 12-19 years in 2005-2006 (3.8 ng/mL). Log-transformed serum PFOA had a strong inverse association with BMIz in the CIN girls (p = 0.0002) and the combined two-site data (p = 0.0008); the joint inverse effect of PFOA and Age*PFOA weakened at age at 10-11 years. However, in the SFBA group alone, the relationship was not significant (p = 0.1641) with no evidence of changing effect with age. The effect of PFOA on waist:height ratio was similar to BMIz at both sites, but we did not find a significant effect of PFOA on waist:hip ratio in either the CIN or SFBA girls.
Conclusions: PFOA is associated with decreased BMI and waist:height ratio in young girls, but the strength of the relationship decreases with age. Site heterogeneity may be due to greater early life exposure in Cincinnati.
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Use of trade names is for identification only and does not imply endorsement by the CDC, the Public Health Service, or the US Department of Health and Human Services.
Copyright © 2019 Elsevier GmbH. All rights reserved.
Figures
References
-
- Buck RC, Franklin J, Berger U, Conder JM, Cousins IT, de Voogt P, Jensen AA, Kannan K, Mabury SA, van Leeuwen SP: Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integrated environmental assessment and management 2011, 7(4):513–541. - PMC - PubMed
-
- Paustenbach DJ, Panko JM, Scott PK, Unice KM: A methodology for estimating human exposure to perfluorooctanoic acid (PFOA): a retrospective exposure assessment of a community (1951–2003). Journal of toxicology and environmental health Part A 2007, 70(1):28–57. - PubMed
-
- EPA and 3M Announce Phase Out of PFOS, May 16, 2000. [https://archive.epa.gov/epapages/newsroom_archive/newsreleases/33aa946e6...]
Publication types
MeSH terms
Substances
Grants and funding
- UL1 RR026314/RR/NCRR NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 ES019453/ES/NIEHS NIH HHS/United States
- U01 ES012801/ES/NIEHS NIH HHS/United States
- U01 ES012770/ES/NIEHS NIH HHS/United States
- U01 ES019435/ES/NIEHS NIH HHS/United States
- T32 ES010957/ES/NIEHS NIH HHS/United States
- U01 ES019457/ES/NIEHS NIH HHS/United States
- R01 ES029133/ES/NIEHS NIH HHS/United States
- U01 ES012771/ES/NIEHS NIH HHS/United States
- U01 ES026119/ES/NIEHS NIH HHS/United States
- P30 ES006096/ES/NIEHS NIH HHS/United States
